Substance Use and Sleep Problems in Patients With Psychotic Disorders

dc.contributor.authorCederlöf Erik
dc.contributor.authorHolm Minna
dc.contributor.authorAhti Johan
dc.contributor.authorLähteenvuo Markku
dc.contributor.authorHietala Jarmo
dc.contributor.authorHäkkinen Katja
dc.contributor.authorIsometsä Erkki
dc.contributor.authorKampman Olli
dc.contributor.authorLahdensuo Kaisla
dc.contributor.authorLönnqvist Jouko
dc.contributor.authorSuvisaari Jaana
dc.contributor.authorTiihonen Jari
dc.contributor.authorWegelius Asko
dc.contributor.authorVeijola Juha
dc.contributor.authorPalotie Aarno
dc.contributor.authorKieseppä Tuula
dc.contributor.authorNiemelä Solja
dc.contributor.authorPaunio Tiina
dc.contributor.organizationfi=psykiatria|en=Psychiatry|
dc.contributor.organization-code1.2.246.10.2458963.20.16217176722
dc.converis.publication-id381352477
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/381352477
dc.date.accessioned2025-08-28T03:36:09Z
dc.date.available2025-08-28T03:36:09Z
dc.description.abstract<p>Background<br>Substance use and sleep problems are common in patients with psychotic disorders, but their associations in these patients have not been evaluated. We aimed to investigate associations between substance use and sleep problems in a large nationwide cohort of patients with a psychotic disorder.</p><p>Study Design<br>This study is part of the Finnish SUPER study, which belongs to the Stanley Global Neuropsychiatric Genomics Initiative. In this cross-sectional, multicenter study, participants (N = 8616) were recruited from primary and specialized healthcare. Patients with schizophrenia, schizoaffective disorder, bipolar disorder, and psychotic depression were included. Information on current alcohol (Alcohol Use Disorders Identification Test-Concise) and cigarette use as well as on lifetime illicit drug use, including cannabis, benzodiazepines, amphetamines, and opioids, was collected using questionnaires. The sleep outcomes in our logistic regression analysis were short (≤6 h) and long sleep (≥10 h) duration, difficulties initiating asleep, early morning awakenings, fatigue, and poor sleep quality (SQ).</p><p>Results<br>Self-reported substance use was associated with a higher prevalence of sleep problems. After adjustments with age, gender, diagnostic group, and living status, hazardous alcohol use (eg, poor SQ odds ratio [OR] = 1.80, 95% CI: 1.49 to 2.16, P < .001), current smoking (short sleep duration OR = 1.28, 95% CI: 1.08 to 1.52, P = .005), and lifetime benzodiazepine misuse (difficulties initiating sleep OR = 2.00, 95% CI: 1.55 to 2.48, P < .001) were associated with sleep problems.</p><p>Conclusions<br>Substance use was associated with sleep problems. Our findings underline the potential benefits of screening substance use when treating sleep problems in patients with psychotic disorders.</p>
dc.identifier.jour-issn2632-7899
dc.identifier.olddbid210881
dc.identifier.oldhandle10024/193908
dc.identifier.urihttps://www.utupub.fi/handle/11111/56653
dc.identifier.urlhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85160058786&origin=inward
dc.identifier.urnURN:NBN:fi-fe2025082788743
dc.language.isoen
dc.okm.affiliatedauthorHietala, Jarmo
dc.okm.affiliatedauthorNiemelä, Solja
dc.okm.discipline3124 Neurology and psychiatryen_GB
dc.okm.discipline3124 Neurologia ja psykiatriafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherOxford University Press
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1093/schizbullopen/sgac073
dc.relation.ispartofjournalSchizophrenia Bulletin Open
dc.relation.issue1
dc.relation.volume4
dc.source.identifierhttps://www.utupub.fi/handle/10024/193908
dc.titleSubstance Use and Sleep Problems in Patients With Psychotic Disorders
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
sgac073.pdf
Size:
290.02 KB
Format:
Adobe Portable Document Format